 | Up a level |
Cornely, Oliver A., Duarte, Rafael F., Haider, Shariq, Chandrasekar, Pranatharthi, Helfgott, David, Lopez Jimenez, Javier, Candoni, Anna 
ORCID: 0000-0003-4436-1310, Raad, Issam, Laverdiere, Michel, Langston, Amelia, Kartsonis, Nicholas, Van Iersel, Marlou, Connelly, Nancy and Waskin, Hetty
(2016).
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease.
J. Antimicrob. Chemother., 71 (3).
S. 718 - 727.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1460-2091
Cornely, Oliver A., Robertson, Michael N., Haider, Shariq, Grigg, Andrew, Geddes, Michelle, Aoun, Mickael, Heinz, Werner J., Raad, Issam, Schanz, Urs, Meyer, Ralf G., Hammond, Sarah P., Mullane, Kathleen M., Ostermann, Helmut, Ullmann, Andrew J., Zimmerli, Stefan, Van Iersel, M. L. P. S., Hepler, Deborah A., Waskin, Hetty, Kartsonis, Nicholas A. and Maertens, Johan (2017). Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. J. Antimicrob. Chemother., 72 (12). S. 3406 - 3414. OXFORD: OXFORD UNIV PRESS. ISSN 1460-2091
Duarte, Rafael F., Lopez-Jimenez, Javier, Cornely, Oliver A., Laverdiere, Michel, Helfgott, David, Haider, Shariq, Chandrasekar, Pranatharthi, Langston, Amelia, Perfect, John, Ma, Lei, van Iersel, Marlou L. P. S., Connelly, Nancy, Kartsonis, Nicholas and Waskin, Hetty (2014). Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia. Antimicrob. Agents Chemother., 58 (10). S. 5758 - 5766. WASHINGTON: AMER SOC MICROBIOLOGY. ISSN 1098-6596